Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Mark Caulfield and Douglas F. Easton Receiving "Lombardy is Research" Award - Milan

Mark Caulfield and Douglas F. Easton during the Awarding Ceremony, on November 8, 2025, in Milan, Italy. The Lombardy Region’s 2025 International “Lombardy is Research” Award, dedicated this year to the theme “Innovative methods of early diagnosis or preventive medicine”, has been jointly awarded to British professors Mark Caulfield and Douglas F. Easton, pioneers in the field of genomic medicine. The award was granted to the two scientists for their “groundbreaking research that has led to the identification of genes associated with increased susceptibility to various diseases, particularly cancer and cardiovascular disease. This work has had a profound impact on early diagnosis, prevention, and precision medicine.” Photo by Maurizio Maule/Fotogramma/ABACAPRESS.COM

E

Mark Caulfield and Douglas F. Easton Receiving "Lombardy is Research" Award - Milan

Mark Caulfield and Douglas F. Easton during the Awarding Ceremony, on November 8, 2025, in Milan, Italy. The Lombardy Region’s 2025 International “Lombardy is Research” Award, dedicated this year to the theme “Innovative methods of early diagnosis or preventive medicine”, has been jointly awarded to British professors Mark Caulfield and Douglas F. Easton, pioneers in the field of genomic medicine. The award was granted to the two scientists for their “groundbreaking research that has led to the identification of genes associated with increased susceptibility to various diseases, particularly cancer and cardiovascular disease. This work has had a profound impact on early diagnosis, prevention, and precision medicine.” Photo by Maurizio Maule/Fotogramma/ABACAPRESS.COM

E

Mark Caulfield and Douglas F. Easton Receiving "Lombardy is Research" Award - Milan

Mark Caulfield and Douglas F. Easton during the Awarding Ceremony, on November 8, 2025, in Milan, Italy. The Lombardy Region’s 2025 International “Lombardy is Research” Award, dedicated this year to the theme “Innovative methods of early diagnosis or preventive medicine”, has been jointly awarded to British professors Mark Caulfield and Douglas F. Easton, pioneers in the field of genomic medicine. The award was granted to the two scientists for their “groundbreaking research that has led to the identification of genes associated with increased susceptibility to various diseases, particularly cancer and cardiovascular disease. This work has had a profound impact on early diagnosis, prevention, and precision medicine.” Photo by Maurizio Maule/Fotogramma/ABACAPRESS.COM

E

Mark Caulfield and Douglas F. Easton Receiving "Lombardy is Research" Award - Milan

Mark Caulfield and Douglas F. Easton during the Awarding Ceremony, on November 8, 2025, in Milan, Italy. The Lombardy Region’s 2025 International “Lombardy is Research” Award, dedicated this year to the theme “Innovative methods of early diagnosis or preventive medicine”, has been jointly awarded to British professors Mark Caulfield and Douglas F. Easton, pioneers in the field of genomic medicine. The award was granted to the two scientists for their “groundbreaking research that has led to the identification of genes associated with increased susceptibility to various diseases, particularly cancer and cardiovascular disease. This work has had a profound impact on early diagnosis, prevention, and precision medicine.” Photo by Maurizio Maule/Fotogramma/ABACAPRESS.COM

E

Mark Caulfield and Douglas F. Easton Receiving "Lombardy is Research" Award - Milan

Mark Caulfield and Douglas F. Easton during the Awarding Ceremony, on November 8, 2025, in Milan, Italy. The Lombardy Region’s 2025 International “Lombardy is Research” Award, dedicated this year to the theme “Innovative methods of early diagnosis or preventive medicine”, has been jointly awarded to British professors Mark Caulfield and Douglas F. Easton, pioneers in the field of genomic medicine. The award was granted to the two scientists for their “groundbreaking research that has led to the identification of genes associated with increased susceptibility to various diseases, particularly cancer and cardiovascular disease. This work has had a profound impact on early diagnosis, prevention, and precision medicine.” Photo by Maurizio Maule/Fotogramma/ABACAPRESS.COM

E

Clarivate Citation Laureate Award Press Conference

Clarivate Citation Laureate Press Conference. photo shows, from right: Kenji Samukawa, former Director and Director-General of the National Cardiovascular Center Research Institute; Masayasu Kojima, Professor Emeritus and Visiting Professor at Kurume University.=September 25,2025,Japan

E

Clarivate Citation Laureate Award Press Conference

Clarivate Citation Laureate Press Conference. photo shows (from right) Kenji Samukawa, former Director and Director-General of the National Cardiovascular Center Research Institute (center), and Masayasu Kojima, Professor Emeritus and Visiting Professor at Kurume University (right).=September 25,2025,Japan

E

Clarivate Citation Laureate Award Press Conference

Clarivate Citation Laureate Press Conference. photo shows (from right) Kenji Samukawa, former Director and Director-General of the National Cardiovascular Center Research Institute (center), and Masayasu Kojima, Professor Emeritus and Visiting Professor at Kurume University (right).=September 25,2025,Japan

E

Clarivate Citation Laureate Award Press Conference

Clarivate Citation Laureate Press Conference. photo shows, from right: Kenji Samukawa, former Director and Director-General of the National Cardiovascular Center Research Institute; Masayasu Kojima, Professor Emeritus and Visiting Professor at Kurume University.=September 25,2025,Japan

E

Sheep survives for three years with artificial heart

STORY: Sheep survives for three years with artificial heart SHOOTING TIME: May 23, 2024 DATELINE: May 25, 2024 LENGTH: 00:00:12 LOCATION: TIANJIN, China CATEGORY: SOCIETY SHOTLIST: 1. various of the sheep with the third-generation ventricular assist device HeartCon "Rocket Heart" in Tianjin TEDA International Cardiovascular Hospital STORYLINE: A sheep celebrated its three-year survival after the implantation of an artificial heart in China's Tianjin. Three years ago, the sheep was successfully implanted with a China-developed ventricular assist device. Up to now, the sheep has set a record for the longest survival of such animal experiments in China. Xinhua News Agency correspondents reporting from Tianjin, China. (XHTV)

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Leading cardiac surgeon and deputy director of the Amosov National Institute of Cardiovascular Surgery Kostiantyn Rudenko poses for a photo after he has performed an open-heart surgery together with specialists from the Amosov National Institute of Cardiovascular Surgery using the Ferrazzi method at St. Panteleimon Clinical Hospital, Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Head of the Heart and Vascular Center of the First Territorial Medical Association of Lviv Roman Domashych poses for a photo after he has performed an open-heart surgery together with specialists from the Amosov National Institute of Cardiovascular Surgery using the Ferrazzi method at St. Panteleimon Clinical Hospital, Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Head of the Heart and Vascular Center of the First Territorial Medical Association of Lviv Roman Domashych (L) and Leading cardiac surgeon and deputy director of the Amosov National Institute of Cardiovascular Surgery Kostiantyn Rudenko shake hands as they pose for a photo having performed an open-heart surgery together with specialists from the Amosov National Institute of Cardiovascular Surgery using the Ferrazzi method at St. Panteleimon Clinical Hospital, Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Leading cardiac surgeon and deputy director of the Amosov National Institute of Cardiovascular Surgery Kostiantyn Rudenko performs an open-heart surgery together with specialists from the Amosov National Institute of Cardiovascular Surgery using the Ferrazzi method at St. Panteleimon Clinical Hospital, Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Leading cardiac surgeon and deputy director of the Amosov National Institute of Cardiovascular Surgery Kostiantyn Rudenko (C) performs an open-heart surgery together with specialists from the Amosov National Institute of Cardiovascular Surgery using the Ferrazzi method at St. Panteleimon Clinical Hospital, Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

Ferrazzi method open heart surgery first ever performed in Lviv

LVIV, UKRAINE - MARCH 27, 2024 - Cardiac surgeons of St. Panteleimon Clinical Hospital together with specialists from the Amosov National Institute of Cardiovascular Surgery perform an open-heart surgery using the Ferrazzi method for the first time in Lviv, western Ukraine.

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui attends a video conference on his way to a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012,

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) talks with his colleague at a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave u

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) learns about the use of OCT equipment at Beijing Anzhen Hospital in Beijing, capital of China, Feb. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave up his do

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui adjusts equipment at a laboratory of Institute of Physics of the Chinese Academy of Sciences in Beijing, capital of China, Jan. 12, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (L) talks with a researcher at a laboratory of Institute of Physics of the Chinese Academy of Sciences in Beijing, capital of China, Jan. 12, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular s

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (L) talks with a doctor about the use of OCT equipment at Beijing Anzhen Hospital in Beijing, capital of China, Feb. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he g

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (back) observes doctors using OCT equipment at Beijing Anzhen Hospital in Beijing, capital of China, Feb. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave up his

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui adjusts OCT equipment at a laboratory of a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012,

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) talks with his partner Dr. Mi Lei in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave up his doctoral studies

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui attends a video conference with experts at a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- This photo taken on Jan. 12, 2024 shows a portrait of Zhu Rui. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave up his doctoral studies and tried to transform the achievements in h

E

2023 Sun Simiao TCM International Forum kicks off in China's Shaanxi

STORY: 2023 Sun Simiao TCM International Forum kicks off in China's Shaanxi DATELINE: May 27, 2023 LENGTH: 0:01:10 LOCATION: XI'AN, China CATEGORY: MEDICINE SHOTLIST: 1. various of 2023 Sun Simiao Traditional Chinese Medicine International Forum 2. SOUNDBITE 1 (Chinese): ZHANG BOLI, Academician with the Chinese Academy of Engineering 3. SOUNDBITE 2 (Russian): BEGENCH H. ANNAYEV, Director of the Turkmenistan National Cardiovascular Medicine Center STORYLINE: 2023 Sun Simiao Traditional Chinese Medicine International Forum kicked off Friday in Tongchuan City, northwest China's Shaanxi Province. Sponsored by the National Administration of Traditional Chinese Medicine and the Shaanxi Provincial People's Government, the forum attracts more than 500 guests, including well-known experts, and scholars both at home and abroad in the field of TCM. SOUNDBITE 1 (Chinese): ZHANG BOLI, Academician with the Chinese Academy of Engineering "We should carry on the essence of TCM while pursuing innovations in the field, so

E

Former Italian PM Berlusconi in intensive care

STORY: Former Italian PM Berlusconi in intensive care DATELINE: April 6, 2023 LENGTH: 00:00:44 LOCATION: MILAN, Italy CATEGORY: POLITICS SHOTLIST: 1. various of the hospital where Silvio Berlusconi under treatment 2. various of the exterior of the hospital STORYLINE: Former Italian Prime Minister Silvio Berlusconi was admitted to the intensive care unit of a Milan hospital Wednesday, the Rome office of his political party Forza Italia has confirmed. News reports say he has severe cardiovascular problems, and has had ongoing health issues for several years. Il Giornale, a Milan daily newspaper owned by the Berlusconi family, said the leader had "difficulty breathing" but was in stable condition at San Raffaele Hospital. Meanwhile, Italian Deputy Prime Minister Antonio Tajani said Berlusconi was "alert and speaking." Berlusconi suffered from a serious case of COVID-19 in 2020, and has also overcome heart surgery and prostate cancer. Forza Italia is a junior partner in the coalition supporting Italian Pri